Clinical, Genetic, and Molecular Determinants of Essential Hyper tension: Mechanisms, Risk Factors, and Emerging Insights

Abstract

The paper explores the clinical, genetic and molecular determinants of essential hypertension using a combined approach to analyzing them. The findings show that the role of clinical factors is approximately 58 percent in the development of hypertension with nearly half of it, or approximately 52 percent, comprised of obesity and the occurrence of the disease increasing by 18 percent among normal-weight individuals to 68 percent among the obese population. The contribution of molecular pathways, including oxidative stress, endothelial dysfunction, is about 27% with a 38 percent increase in reactive oxygen species and 35 percent prevalence of endothelial dysfunction. A direct role is 15% with a genetic background with up to 75% moderate and high susceptibility.

The results also indicate that clinical and molecular variables are strongly correlated and the correlation coefficients are greater than 0.70 which mean that they are highly interdependent. The incidence of hypertension rises by 28% to 74% with one and many risk factors respectively, and hence the incidence has almost tripled. Moreover, 78 percent of the study population members belong to pre-hypertensive bracket or hypertensive which highlights a serious social health problem.

In general, the study establishes the fact that essential hypertension is a complex condition that needs a holistic and combined approach to management. The findings are used to develop personalized treatment options and support the need to diagnose the disease in its early stages, change lifestyle and provide molecular-based interventions to improve the clinical outcome and reduce the burden of the disease.